ERBB2 and breast cancer: Based on the presence or absence of these markers, breast cancer is commonly classified into at least four intrinsic subtypes, Luminal A (LA), Luminal B (LB), HER2-enriched, and triple-negative breast cancer (TNB), each associated with distinct clinical outcomes [1,6].